Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
CollPlant Biotechnologies Ltd. Sponsored ADR (CLGN) had Return on Equity of -188.93% for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$2.37M |
|
$-11.49M |
|
$0.83M |
|
$1.54M |
|
$13.85M |
|
$-11.48M |
|
$-0.01M |
|
$-11.49M |
|
$-11.49M |
|
$-11.49M |
|
$-11.49M |
|
$-11.49M |
|
$-11.49M |
|
$-11.48M |
|
$-10.57M |
|
12.20M |
|
12.20M |
|
$-0.94 |
|
$-0.94 |
|
| Balance Sheet Financials | |
$6.75M |
|
$1.46M |
|
$4.04M |
|
$10.79M |
|
$2.67M |
|
-- |
|
$2.03M |
|
$4.70M |
|
$6.08M |
|
$6.01M |
|
$6.08M |
|
12.80M |
|
| Cash Flow Statement Financials | |
$-9.42M |
|
$-0.03M |
|
$3.10M |
|
$11.91M |
|
$5.59M |
|
$-6.32M |
|
$1.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.53 |
|
-- |
|
-- |
|
-- |
|
-- |
|
64.78% |
|
-484.31% |
|
-484.31% |
|
-445.85% |
|
-484.56% |
|
-484.56% |
|
$-9.45M |
|
-- |
|
-- |
|
-- |
|
0.22 |
|
1.46 |
|
10.58 |
|
34.48 |
|
|
Return on Equity |
-188.93% |
-191.23% |
|
-106.53% |
|
-188.93% |
|
$0.47 |
|
$-0.77 |
|
$-0.77 |
|